Patent ID: 6613349
Filing Date: 2003-09-02
Classification: A61K,A61P

Abstract:
A method of treating soft tissue infections in a useful warm blooded mammal who is in need of such treatment which comprises administration of a pharmaceutical composition comprising a transdermally effective amount of an Oxazolidinone to the skin at a site that is not the site of infection, wherein the Oxazolidinone is selected from the group consisting of:(S)-N-[[3-[3-fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; (S)-N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; [4(S)-cis]-(âˆ’)-N-[[3-[3-fluoro-4-(tetrahydro-1-oxido-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; and pharmaceutically acceptable salts thereof.